Ontario to allow pharmacists to prescribe antiviral Paxlovid for COVID-19
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $1.44 a week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $5.77 plus GST every four weeks. After 52 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 08/12/2022 (1424 days ago), so information in it may no longer be current.
TORONTO – Ontario will soon allow pharmacists to prescribe an antiviral drug used to reduce severe outcomes from COVID-19.
Starting on Dec. 12, pharmacists can prescribe Paxlovid to eligible patients at no cost, both in person or virtually.
“By increasing access to these treatments in more convenient ways, we are helping to keep people healthier and reduce COVID-19-related hospital admissions,” Health Minister Sylvia Jones announced on Thursday.
Those eligible for Paxlovid must have COVID-19 symptoms as well as a positive COVID-19 test, either from a PCR test or a rapid test, and seek treatment within five days of symptom onset, the province said.
Eligible individuals include those 60 years and older, those who are aged 18 or older who are immunocompromised, and those over 18 who are at a higher risk of severe COVID-19 outcomes with chronic conditions such as diabetes, heart disease or lung disease.
Pharmacists have already been dispensing Paxlovid in some 4,000 locations across the province for those who have a prescription from their physician, Jones said
“While it is a voluntary program, we are quite optimistic that there will be many pharmacists that choose to do this because it is another pathway for them to assist their patients directly,” Jones said.
“So it’s really about getting access into community faster.”
Justin Bates, the CEO of the Ontario Pharmacists Association, said the Paxlovid prescribing power builds on the work pharmacists have been doing with the drug.
“For the last several months in dispensing Paxlovid and dealing with some of the complexities in the drug-to-drug interactions, which really leverages the pharmacist’s expertise, training, and education, now we can reduce the barriers to make sure that more Ontarians have access to this important medication,” Bates said.
He said he expects the majority of pharmacies “will take this on.”
Last month, Ontario’s chief medical officer of health said the move would keep people out of hospital, especially in rural areas where access to primary care physicians can be limited.
“Authorizing pharmacists to prescribe Paxlovid will expand access and offer increased protection to the most vulnerable and mitigate pressures on the province’s hospital capacity,” Dr. Kieran Moore wrote in a statement Thursday.
This report by The Canadian Press was first published Dec. 8, 2022.
